43 China A-Shares Face Lockup Expiry Next Week, 15.1B Yuan to Unlock

Lockup expiries of this scale matter less for the headline yuan figure than for the distribution: a handful of names, First Pharma-U especially, face supply shocks that are large relative to their own float, while most of the 43 do not. That split is what separates mechanical selling pressure from genuine sentiment tests. The inclusion of companies that just swung to first-half profit complicates the read — improving earnings can absorb unlocks, but the pairing also invites scrutiny of whether those turns are durable enough to meet newly tradable supply. Whether the high-ratio names absorb the release without disorderly trading is the open question.